2008
Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study
Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O’Connor P, Schottenfeld RS, Fiellin DA. Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study. Journal Of General Internal Medicine 2008, 24: 218-225. PMID: 19089500, PMCID: PMC2628993, DOI: 10.1007/s11606-008-0881-9.Peer-Reviewed Original ResearchConceptsBuprenorphine maintenance treatmentOffice-based practicePhysicians' perceptionsPatient-related barriersOffice-based physiciansLack of remunerationBuprenorphine treatmentOpioid dependenceMaintenance treatmentPhysician barriersMethadone maintenancePrimary careResultsEighty percentLow prevalenceClinical practiceMedical providersMultidisciplinary teamPatient careInternal medicinePhysician facilitatorsInfectious diseasesAddiction medicinePhysiciansQualitative software programDesignQualitative study
2002
A Staging System to Predict Prognosis Among Methadone Maintenance Patients, Based on Admission Characteristics
Favrat B, Rao S, O'Connor P, Schottenfeld R. A Staging System to Predict Prognosis Among Methadone Maintenance Patients, Based on Admission Characteristics. Substance Abuse 2002, 23: 233-244. DOI: 10.1023/a:1021150217215.Peer-Reviewed Original ResearchStaging systemAdverse dischargeOpioid maintenance therapyU.S. general internistsMethadone maintenance patientsMethadone maintenance treatmentMain outcome measuresMethadone maintenance programProportional hazards modelIllicit drug useHistory of diseaseOutset of treatmentPrevious prison termsMaintenance therapyConsecutive patientsEntire cohortMaintenance patientsMaintenance treatmentAdmission characteristicsOutcome measuresGeneral internistsPrognostic studiesStage IIIPatientsStage IA Staging System to Predict Prognosis among Methadone Maintenance Patients, Based on Admission Characteristics
Favrat B, Rao S, O'Connor PG, Schottenfeld R. A Staging System to Predict Prognosis among Methadone Maintenance Patients, Based on Admission Characteristics. Substance Abuse 2002, 23: 233-244. PMID: 12438836, DOI: 10.1080/08897070209511496.Peer-Reviewed Original ResearchConceptsStaging systemAdverse dischargeOpioid maintenance therapyU.S. general internistsMethadone maintenance patientsMethadone maintenance treatmentMain outcome measuresMethadone maintenance programProportional hazards modelIllicit drug useHistory of diseaseOutset of treatmentPrevious prison termsMaintenance therapyConsecutive patientsEntire cohortMaintenance patientsMaintenance treatmentAdmission characteristicsOutcome measuresGeneral internistsPrognostic studiesStage IIIPatientsStage INew federal initiatives to enhance the medical treatment of opioid dependence.
Fiellin DA, O'Connor PG. New federal initiatives to enhance the medical treatment of opioid dependence. Annals Of Internal Medicine 2002, 137: 688-92. PMID: 12379070, DOI: 10.7326/0003-4819-137-8-200210150-00014.Peer-Reviewed Original ResearchConceptsOpioid dependenceMedical treatmentOpioid agonist medicationsRole of internistsAgonist medicationsPharmacologic treatmentMaintenance treatmentNew medicationsMedical conditionsOffice settingSubstantial healthMedicationsPatientsTreatmentInternistsRecent federal initiativesFederal initiativesNew federal initiativesComplicationsCare
2000
Thrice-weekly versus daily buprenorphine maintenance
Schottenfeld R, Pakes J, O’Connor P, Chawarski M, Oliveto A, Kosten T. Thrice-weekly versus daily buprenorphine maintenance. Biological Psychiatry 2000, 47: 1072-1079. PMID: 10862807, DOI: 10.1016/s0006-3223(99)00270-x.Peer-Reviewed Original ResearchConceptsSublingual buprenorphineMaintenance treatmentSelf-reported illicit drug useDrug useOpioid agonist maintenance treatmentOpioid-positive urine testsAgonist maintenance treatmentDaily clinic attendanceDaily sublingual buprenorphineThrice-weekly dosingOpioid-dependent patientsUrine toxicology testsSignificant differencesIllicit drug useSelf-reported numberBuprenorphine maintenanceClinic attendanceWeekly doseIllicit opioidsMedication complianceThrice weeklyUrine testsOutcome measuresBuprenorphineCounseling attendance
1996
Substance Abuse and HIV/AIDS in Poland: Opportunities for Educational Exchange1
O'Connor P, Williams A. Substance Abuse and HIV/AIDS in Poland: Opportunities for Educational Exchange1. Substance Abuse 1996, 17: 101-109. DOI: 10.1080/08897079609444734.Peer-Reviewed Original ResearchInjection drug usersMethadone maintenance treatmentEpidemic of HIVSubstance abuse treatment systemLong-term residential treatmentEffective substance abuse treatmentClinical treatment approachesHIV/AIDSSubstance abuse treatmentHIV infectionMaintenance treatmentClean needlesHIV riskTreatment approachesDrug usersMedical careCocaine useMedical UniversityAbuse treatmentSubstance abuseResidential treatmentCareTreatmentAddiction problemsOpioids
1994
HIV infection and cocaine use in methadone maintained and untreated intravenous drug users
Meandzija B, O'Connor P, Fitzgerald B, Rounsaville B, Kosten T. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug And Alcohol Dependence 1994, 36: 109-113. PMID: 7851277, DOI: 10.1016/0376-8716(94)90092-2.Peer-Reviewed Original ResearchConceptsIntravenous drug usersMethadone maintenance treatmentMethadone maintenance programHIV infectionCocaine useMore cocaine useMaintenance treatmentRisk factorsDrug usersMethadone maintenance treatment groupHuman immunodeficiency virus (HIV) transmissionAfrican AmericansMaintenance treatment groupNon-infected subjectsInjection frequencyHIV-negativeHIV testingDrug injectionStratified analysisTreatment groupsTotal cocaineHIVRisk behaviorsGreater riskInfection